Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5110152

COc1cc(CN(CCN)C(=O)c2cccs2)ccc1OCc1ccc(F)cc1F.O=C(O)C(F)(F)F

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 4/20 0.62
GAA P10253 2/20 0.44
TSHR P16473 1/20 0.44
ALDH1A1 P00352 5/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KDM4E B2RXH2 4/20 0.41
FFAR4 Q5NUL3 2/20 0.39
LPAR1 Q92633 1/20 0.39
LPAR5 Q9H1C0 1/20 0.39
RAF1 P04049 1/20 0.38
MAP2K1 Q02750 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
PPARA Q07869 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14078258 0.95 TRPM8 (0.68) TRPM8GAATSHRALDH1A1NPSR1
Trifluoroacetic Acid SCHEMBL5114908 0.92 TRPM8 (0.59) TRPM8GAATSHRALDH1A1NPSR1
SCHEMBL5113509 0.87 TRPM8 (0.60) TRPM8GAATSHRALDH1A1NPSR1
SCHEMBL14078259 0.86 TRPM8 (0.65) TRPM8GAATSHRALDH1A1NPSR1
SCHEMBL5110070 0.86 TRPM8 (0.81) TRPM8GAATSHRALDH1A1NPSR1
SCHEMBL14078273 0.85 TRPM8 (0.54) TRPM8TSHRALDH1A1KDM4ELPAR1
Trifluoroacetic Acid SCHEMBL5315884 0.84 TRPM8 (0.53) TRPM8GAATSHRALDH1A1KDM4E
SCHEMBL14078232 0.84 TRPM8 (0.56) TRPM8GAATSHRALDH1A1NPSR1
SCHEMBL14078314 0.84 TRPM8 (0.53) TRPM8GAAALDH1A1KDM4ELPAR1
SCHEMBL14078279 0.83 TRPM8 (0.53) TRPM8GAATSHRALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214654-A1 Substituted Benzyloxy-Phenylmethylamide Derivatives BAYER HEALTHCARE AG (DE) 2008-09-04 US disclosed
EP-1802600-A1 SUBSTITUTED 4-BENZYLOXY-PHENYLMETHYLAMIDE DERIVATIVES AS COLD MENTHOL RECEPTOR-1 (CMR-1) ANTAGONITS FOR THE TREATMENT OF UROLOGICAL DISORDERS Bayer HealthCare AG (DE) 2007-07-04 EP disclosed
WO-2006040136-A1 SUBSTITUTED 4-BENZYLOXY-PHENYLMETHYLAMIDE DERIVATIVES AS COLD MENTHOL RECEPTOR-1 (CMR-1) ANTAGONISTS FOR THE TREATMENT OF UROLOGICAL DISORDER BAYER HEALTHCARE AG (DE) 2006-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214654-A1 Substituted Benzyloxy-Phenylmethylamide Derivatives OPRL1, ADRA1A, CNR1 TRPM8 124/4885GAA 1314/4885TSHR 4414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.